ML | pharmaphorum

R&D

As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.

News

Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

ML